跳至主要内容
临床试验/IRCT20221018056229N1
IRCT20221018056229N1已完成3 期

Investigating the efficacy and safety of platelet rich plasma and topical clobetasol in treating hair loss of patients with lichen planopilaris in comparison to the patients who only use topical clobetasol

Iran University of Medical Sciences0 个研究点目标入组 22 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
22

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Age: 18 years old and more
  • Definite and resistant hair loss due to LPP
  • The patient gives informed consent
  • The patient can participate in regular follow up meetings
  • The patient does not have serious internal disease
  • The patient does not have cutaneous disease in the site of treatment

排除标准

  • History of any remedies taken in last month
  • Positive history of liver, kidney, pulmonary, cardiac, and intestinal disease and malignancies
  • Taking any medications for any disease which makes drug reactions possible
  • Accompanying of LPP with generalized lichen planus or erosive mucosal form
  • Other forms of noncicatricial or other forms of cicatricial alopecia except LPP

研究者

相似试验